STAG2 and myelodysplastic syndrome: The co-occurring mutations included genes encoding basic transcriptional regulators RUNX1 and BCOR, and chromatin modifiers ASXL1, SRSF2 and TET2. The presence of mutations was associated with the overall poor survival, specifically the MDS patients carrying STAG2 mutations had short survival time.